Condition: Squamous Cell Carcinoma · Nonmelanoma Skin Cancer · Cutaneous Squamous Cell Carcinoma · Sponsor: Indiana University
The purpose of this study is to research if a type of biopsy known as sentinel lymph node biopsy (SLNB) can help in determining the rate of tumor deposits that are hard to detect and identify in node-negative cutaneous squamous cell carcinoma of the head or neck.
This description comes directly from the study's public registry record.
Azeezat Yekinni · 317-529-6883 · ayekinn@iu.edu
Jessica Yesensky, MD · 317- 948-3226
Always discuss trial participation with your own doctor first.
| Indiana University Melvin & Bren Simon Cancer Center | Indianapolis, Indiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05108090